A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients

Clinical trial NCT00969722 · TERMINATED

Trial details

NCT number: NCT00969722
Sponsor: United Therapeutics
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Refractory Neuroblastoma

Start date: 2009-08-01
Primary completion: 2010-08-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.